{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:54:13Z","timestamp":1789872853576,"version":"4.0.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T00:00:00Z","timestamp":1403740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-1947-8-234","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T11:09:45Z","timestamp":1403780985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An effective 5-fluorouracil, levofolinate, and oxaliplatin therapy for recurrent breast cancer: a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Makoto","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Yaginuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michitoshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Okuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Tomiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,26]]},"reference":[{"key":"2840_CR1","unstructured":"Guidelines for Colorectal Cancer.\n                    http:\/\/www.jsccr.jp\/index.html\n                    \n                  ,"},{"key":"2840_CR2","volume-title":"TNM Classification of Malignant Tumours","author":"Union for International Cancer Control","year":"2009","unstructured":"Union for International Cancer Control: TNM Classification of Malignant Tumours. 2009, UICC\u2013Wiley-Blackwell, 7","edition":"7"},{"key":"2840_CR3","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE)","author":"U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute","year":"2009","unstructured":"U.S. Department of Health and Human Services. National Institutes of Health. National Cancer Institute: Version 4.0. U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). 2009, National Institutes of Health. National Cancer Institute"},{"key":"2840_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauera","year":"2009","unstructured":"Eisenhauera EA, Therasseb P, Bogaertsc J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther M, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45: 228-247.","journal-title":"Eur J Cancer"},{"key":"2840_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.14789\/pjmj.52.546","volume":"52","author":"M Saito","year":"2006","unstructured":"Saito M: Chemotherapy for breast cancer. Juntendo Med J. 2006, 52: 546-558.","journal-title":"Juntendo Med J"},{"key":"2840_CR6","first-page":"439","volume":"57","author":"T Ide","year":"2006","unstructured":"Ide T, Asahi M, Omori S: The side effect and countermeasure of oral anticancer drugs in breast cancer ambulatory. J Pract Pharm. 2006, 57: 439-445.","journal-title":"J Pract Pharm"},{"key":"2840_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3862\/jcoloproctology.45.336","volume":"45","author":"K Shinohara","year":"1992","unstructured":"Shinohara K, Konishi T, Ushirokohji Y, Yoshino G, Yuzumoto S, Sanjo K, Idezuki Y: Biochemically modulated chemotherapy with leucovorin and 5-fluorouracil for metastasis of colorectal cancer. J Jpn Soc Coloproctol. 1992, 45: 336-340.","journal-title":"J Jpn Soc Coloproctol"},{"key":"2840_CR8","first-page":"232","volume":"54","author":"T Tamura","year":"2006","unstructured":"Tamura T: An overview of chemotherapy and current topics for colorectal cancer in Japan. Jpn J Chemother. 2006, 54: 232-238.","journal-title":"Jpn J Chemother"},{"key":"2840_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12032-011-9839-6","volume":"29","author":"S Sun","year":"2012","unstructured":"Sun S, Wang LP, Zhang J, Yang XY, Zhang QL, Jia Z, Hu XC, Wang BY: Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients. Med Oncol. 2012, 29: 418-424.","journal-title":"Med Oncol"},{"key":"2840_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/annonc\/mdg172","volume":"14","author":"D Pectasides","year":"2003","unstructured":"Pectasides D, Pectasides M, Farmakis D, Bountouroglou N, Nikolaou M, Koumpou M, Mylonakis N, Kosmas C: Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study. Ann Oncol. 2003, 14: 537-542.","journal-title":"Ann Oncol"},{"key":"2840_CR11","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1200\/JCO.2002.06.164","volume":"20","author":"L Zelek","year":"2002","unstructured":"Zelek L, Cottu P, Tubiana-Hulin M, Vannetzel JM, Chollet P, Misset JL, Chouaki N, Marty M, Gamelin E, Culine S, Dieras V, Mackenzie S, Spielmann M: Phase II study of oxaliplatin and fluorouracil in taxane and anthracycline-pretreated breast cancer patients. J Clin Oncol. 2002, 20: 2551-2558.","journal-title":"J Clin Oncol"},{"key":"2840_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0959-8049(96)00370-X","volume":"33","author":"AD de Gramont","year":"1997","unstructured":"de Gramont AD, Vignoud J, Tournigand C, Louvet C, Andr\u00e9 T, Varette C, Raymond E, Moreau S, Le Bail N, Krulik M: Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer. 1997, 33: 214-219.","journal-title":"Eur J Cancer"},{"key":"2840_CR13","first-page":"1467","volume":"34","author":"T Sagawa","year":"2007","unstructured":"Sagawa T, Sato Y, Takayama T, Kuroda H, Hirakawa M, Abe S, Iyama S, Sakamaki S, Kato J, Niitsu Y: Fifth-line chemotherapy for metastatic gastric cancer \u2013 a case responding to modified FOLFOX6. Jpn J Cancer Chemother. 2007, 34: 1467-1471.","journal-title":"Jpn J Cancer Chemother"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-8-234\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-234.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T02:46:05Z","timestamp":1548125165000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-8-234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,26]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2840"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-8-234","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,26]]},"assertion":[{"value":"22 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"234"}}